Cargando…
Neutralizing Antibody and T-Cell Responses against SARS-CoV-2 Wild-Type and Variants of Concern in Chronic Obstructive Pulmonary Disease Subjects after ChAdOx-1/ChAdOx-1 Homologous Vaccination: A Preliminary Study
Data on immunogenicity of adenovirus-vectored vaccine in chronic obstructive pulmonary disease (COPD) patients is limited. Therefore, we aimed to determine the humoral and cellular immune responses after homologous ChAdOx-1 vaccination in subjects with COPD. COPD subjects and age- and sex-matched he...
Autores principales: | Chaiwong, Warawut, Takheaw, Nuchjira, Laopajon, Witida, Pata, Supansa, Duangjit, Pilaiporn, Inchai, Juthamas, Pothirat, Chaicharn, Bumroongkit, Chaiwat, Deesomchok, Athavudh, Theerakittikul, Theerakorn, Limsukon, Atikun, Tajarernmuang, Pattraporn, Niyatiwatchanchai, Nutchanok, Trongtrakul, Konlawij, Chuensirikulchai, Kantinan, Cheyasawan, Passaworn, Liwsrisakun, Chalerm, Kasinrerk, Watchara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781239/ https://www.ncbi.nlm.nih.gov/pubmed/36560586 http://dx.doi.org/10.3390/vaccines10122176 |
Ejemplares similares
-
Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine
por: Liwsrisakun, Chalerm, et al.
Publicado: (2022) -
Levels and durability of neutralizing antibodies against SARS-CoV-2 Omicron and other variants after ChAdOx-1 or BNT162b2 booster in CoronaVac-primed elderly individuals
por: Takheaw, Nuchjira, et al.
Publicado: (2023) -
Correlation Analysis of Anti-SARS-CoV-2 RBD IgG and Neutralizing Antibody against SARS-CoV-2 Omicron Variants after Vaccination
por: Takheaw, Nuchjira, et al.
Publicado: (2022) -
Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
por: Berg, Adam, et al.
Publicado: (2021) -
Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
por: Zhang, Cheng, et al.
Publicado: (2023)